Novo buys Norway’s Xellia for $700 million

Share:

Novo A/S, the holding company of Denmark’s Novo Nordisk, has acquired Xellia Pharmaceuticals of Norway in a deal valued at $700 million.

read all at

http://www.pharmatimes.com/Article/13-05-21/Novo_buys_Norway_s_Xellia_for_700_million.aspx

Tweet